Eyepatch with dissolvable needles used to treat eye disease

November 12, 2018 by Bob Yirka, Medical Xpress report
Illustration of eye-contact patch for ocular drug delivery. The eye patch is equipped with an array of self-implantable micro-drug-reservoirs. Credit: Nature Communications (2018). DOI: 10.1038/s41467-018-06981-w

A team of researchers affiliated with several institutions in Singapore has developed an eyepatch with dissolvable needles for use in treating eye diseases. In their paper published in the journal Nature Communications, the group describes their eyepatch and how well it worked in mice.

Current methods used to treat eye diseases such as glaucoma and include applying or using needles to inject drugs. But eyedrops fail to deliver enough drugs and using needles to poke through the cornea can be risky. And neither method allows for applying doses of drugs over an extended period of time. For these reasons, scientists seek a better treatment. In this new effort, the researchers have come up with a new method that does not involve eyedrops or traditional needles—instead, dissolvable needles deliver an initial strong dose and then slowly deliver a secondary dose.

The new delivery method is applied to the front of the eye like a on the skin—it is put in place by hand. The eye patch is made in two layers—a base and a span of microneedles. When the patch is applied to the eye, eye fluid seeps into the space between the base and the microneedles, dissolving the material holding them together. At this point, the patch can be removed—the microneedles stay behind, embedded in the cornea. The microneedles are made in two layers, as well. The outer layer dissolves right away, delivering an initial dose of a drug. The inner layer takes several days to dissolve, delivering a secondary dose over time.

The researchers tested their new eye patch on lab mice—each had a case of corneal neovascularization, in which blood vessels grow into the cornea, obscuring vision. Prior research had shown that an antibody called DC101 blocks a protein needed for blood vessel progression. Using the antibody as an ingredient in the microneedles worked as hoped. The researchers report that they were 90 percent effective in treating the disease. More testing is required to determine if there are undesirable side effects before testing can begin in humans.

The microneedles on the eye patch can be loaded with drugs. Worn like contact lenses, the patch is painless and minimally invasive. The drug is released slowly as the biodegradable microneedles dissolve in the corneal tissue. Credit: NTU Singapore
(L-R) Assistant Professor Wang Xiaomeng from NTU's Lee Kong Chian School of Medicine and Professor Chen Peng from the NTU School of Chemical and Biomedical Engineering are part of an NTU team that developed a 'contact lens' eye patch to treat eye diseases. Painless and minimally invasive, the patch could potentially be a viable alternative to the current treatment options, which face poor patient compliance. Credit: NTU Singapore

Explore further: Tiny needles offer potential new treatment for two major eye diseases

More information: Aung Than et al. Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery, Nature Communications (2018). DOI: 10.1038/s41467-018-06981-w

Related Stories

Tiny needles offer potential new treatment for two major eye diseases

November 13, 2014
Needles almost too small to be seen with the unaided eye could be the basis for new treatment options for two of the world's leading eye diseases: glaucoma and corneal neovascularization.

Recommended for you

Injection improves vision in a form of childhood blindness

December 17, 2018
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the ...

Researchers report vision-based neurotransmitter events for the first time

November 27, 2018
How does vision work, and what happens in the brain during the process? As simple as this question may sound, it has yet to be scientifically clarified. Dr. Valentin Riedl of the Technical University of Munich (TUM) and his ...

Minimally invasive retinal detachment has better outcomes, clinical trial findings

November 26, 2018
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital ...

Scientists combine technologies to view the retina in unprecedented detail

November 14, 2018
By combining two imaging modalities—adaptive optics and angiography—investigators at the National Eye Institute (NEI) can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina. Resolving ...

Eyepatch with dissolvable needles used to treat eye disease

November 12, 2018
A team of researchers affiliated with several institutions in Singapore has developed an eyepatch with dissolvable needles for use in treating eye diseases. In their paper published in the journal Nature Communications, the ...

Calcifications in the eye increase risk for progression to advanced AMD by more than six times

November 8, 2018
Calcified nodules in the retina are associated with progression to late stages of age-related macular degeneration (AMD). Experts from Queen's University Belfast, working in partnership with the University of Alabama of Birmingham ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.